Bank of America
FLNA

Bank of America’s Filana Therapeutics FLNA Stock Holding History

Bank of America’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,531
Closed -$26.8K – 6690
2025
Q4 		$26.8K Sell
13,531
-14,697
-52% -$47.1K ﹤0.01% 5992
2025
Q3 		$82.1K Sell
28,228
-975
-3% -$2.24K ﹤0.01% 6675
2025
Q2 		$52.9K Sell
29,203
-87,617
-75% -$156K ﹤0.01% 6790
2025
Q1 		$175K Sell
116,820
-362,408
-76% -$915K ﹤0.01% 6249
2024
Q4 		$1.13M Buy
479,228
+388,374
+427% +$6.82M ﹤0.01% 4928
2024
Q3 		$2.67M Sell
90,854
-29,737
-25% -$685K ﹤0.01% 4320
2024
Q2 		$1.49M Sell
120,591
-23,314
-16% -$491K ﹤0.01% 4644
2024
Q1 		$2.92M Sell
143,905
-90,036
-38% -$2.07M ﹤0.01% 4129
2023
Q4 		$5.27M Sell
233,941
-387,862
-62% -$8.19M ﹤0.01% 3510
2023
Q3 		$10.3M Buy
621,803
+448,093
+258% +$8.88M ﹤0.01% 2682
2023
Q2 		$4.26M Sell
173,710
-45,059
-21% -$1.09M ﹤0.01% 3560
2023
Q1 		$5.28M Buy
218,769
+117,742
+117% +$3.26M ﹤0.01% 3493
2022
Q4 		$2.98M Sell
101,027
-164,973
-62% -$5.93M ﹤0.01% 3891
2022
Q3 		$11.1M Buy
266,000
+123,547
+87% +$3.34M ﹤0.01% 2505
2022
Q2 		$4.01M Buy
142,453
+112,808
+381% +$2.85M ﹤0.01% 3639
2022
Q1 		$1.1M Sell
29,645
-245,462
-89% -$10.4M ﹤0.01% 5138
2021
Q4 		$12M Buy
275,107
+123,437
+81% +$6.47M ﹤0.01% 2739
2021
Q3 		$9.42M Buy
151,670
+127,274
+522% +$10.6M ﹤0.01% 2922
2021
Q2 		$2.08M Sell
24,396
-10,245
-30% -$549K ﹤0.01% 4281
2021
Q1 		$1.56M Buy
34,641
+21,037
+155% +$827K ﹤0.01% 4467
2020
Q4 		$92K Sell
13,604
-89,114
-87% -$796K ﹤0.01% 6028
2020
Q3 		$1.18M Buy
102,718
+92,638
+919% +$418K ﹤0.01% 4085
2020
Q2 		$31K Buy
10,080
+6,340
+170% +$28.8K ﹤0.01% 6150
2020
Q1 		$15K Buy
3,740
+25
+0.7% +$166 ﹤0.01% 6254
2019
Q4 		$19K Sell
3,715
-2,143
-37% -$3.7K ﹤0.01% 6519
2019
Q3 		$7K Buy
5,858
+3,626
+162% +$4.66K ﹤0.01% 6790
2019
Q2 		$3K Hold
2,232
– – ﹤0.01% 6914
2019
Q1 		$3K Sell
2,232
-143
-6% -$164 ﹤0.01% 6860
2018
Q4 		$2K Hold
2,375
– – ﹤0.01% 6907
2018
Q3 		$2K Sell
2,375
-286
-11% -$435 ﹤0.01% 7034
2018
Q2 		$5K Hold
2,661
– – ﹤0.01% 6799
2018
Q1 		$19K Buy
2,661
+286
+12% +$1.93K ﹤0.01% 6393
2017
Q4 		$10K Sell
2,375
-1,429
-38% -$5.77K ﹤0.01% 6606
2017
Q3 		$16K Hold
3,804
– – ﹤0.01% 6372
2017
Q2 		$16K Buy
3,804
+1
+0% +$5 ﹤0.01% 6291
2017
Q1 		$24K Sell
3,803
-22
-0.6% -$100 ﹤0.01% 6248
2016
Q4 		$16K Sell
3,825
-252
-6% -$1.17K ﹤0.01% 6427
2016
Q3 		$29K Sell
4,077
-264
-6% -$4.37K ﹤0.01% 5976
2016
Q2 		$66K Buy
4,341
+341
+9% +$5.41K ﹤0.01% 5716
2016
Q1 		$62K Hold
4,000
– – ﹤0.01% 5694
2015
Q4 		$49K Sell
4,000
-4,294
-52% -$56.8K ﹤0.01% 6049
2015
Q3 		$106K Buy
8,294
+1,246
+18% +$15.7K ﹤0.01% 5647
2015
Q2 		$86K Buy
7,048
+561
+9% +$7.69K ﹤0.01% 5672
2015
Q1 		$86K Sell
6,487
-413
-6% -$5.57K ﹤0.01% 5394
2014
Q4 		$98K Sell
6,900
-54
-0.8% -$935 ﹤0.01% 5896
2014
Q3 		$190K Sell
6,954
-10,621
-60% -$323K ﹤0.01% 5427
2014
Q2 		$708K Sell
17,575
-2,485
-12% -$92K ﹤0.01% 4303
2014
Q1 		$773K Buy
20,060
+1,466
+8% +$51.8K ﹤0.01% 4165
2013
Q4 		$632K Sell
18,594
-835
-4% -$22.2K ﹤0.01% 4547
2013
Q3 		$370K Sell
19,429
-4,707
-20% -$82.3K ﹤0.01% 4890
2013
Q2 		$373K Buy
+24,136
New +$510K ﹤0.01% 5031

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Bank of America's FLNA Position: Q1 2026 in Review

Bank of America sold out of Filana Therapeutics (FLNA) in Q1 2026, closing a stake of 13,531 shares — an estimated $26.8K sold.

Bank of America first reported a position in FLNA in Q2 2013 and held it in 51 quarters. The position peaked at $12M in Q4 2021. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Bank of America reported no remaining Filana Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 13,531 Filana Therapeutics shares in Q1 2026, an estimated $26.8K.
  • Bank of America first reported a position in Filana Therapeutics in Q2 2013 and held it in 51 quarters.
  • Bank of America's Filana Therapeutics position peaked at $12M in Q4 2021.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.